The public hospital system saw its net revenue decline 6.2 percent to $260.6 million in the three months ended March 31. In the same period last year, Erlanger recorded a net revenue of $277.8 million. Net patient service revenue saw a 9.8 percent decline year over year to $244.5 million.
Erlanger’s expenses decreased 7.8 percent year over year in the third quarter to $252.4 million. Erlanger attributed the decrease in the third quarter to a drop in supply and medication expenses as well as a decline in wages, salaries and benefits with labor management controls.
Erlanger ended the third quarter of fiscal 2021 with an operating income of $8.1 million, up from $4.2 million recorded in the third quarter of fiscal 2020.
Access the full report here.
More articles on healthcare finance:
What’s the most common service for which patients face out-of-networks bills?
White House completes review of CMS inpatient payment rate changes
Physician viewpoint: Low reimbursement is causing an anesthesiologist shortage in Michigan
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
